ITOS
Iteos Therapeutics, Inc.
Director David Hallal sold $2.2M of Iteos Therapeutics, Inc.
Sold$2,178,500
$43.57Price
50,000Shares
−100%Stake
What ITOS did after the filing
- The stock from Thu, Dec 23 open, $46.26
- −21.5%
- S&P 500, same days
- −4.6%
Measured over 30 trading days, to the Feb 7 close.
Traded Mon, Dec 20. Filed Wed, Dec 22, 7:59 PM ET, after the close. Returns use the Dec 23 open and the Feb 7 close. Not investment advice.